Empagliflozin attenuates ischemia and reperfusion injury through LKB1/AMPK signaling pathway

Published 2019 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Empagliflozin attenuates ischemia and reperfusion injury through LKB1/AMPK signaling pathway
Authors
Keywords
-
Journal
MOLECULAR AND CELLULAR ENDOCRINOLOGY
Volume 501, Issue -, Pages 110642
Publisher
Elsevier BV
Online
2019-11-21
DOI
10.1016/j.mce.2019.110642

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.